[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

The Nobel Prize That Proved Einstein Wrong

Put Castor Oil Here Before Bed – The Results After 7 Days Are Shocking

Sounds Like They're Trying to Get Ghislaine Maxwell out of Prison

Mississippi declared a public health emergency over its infant mortality rate (guess why)

Andy Ngo: ANTIFA is a terrorist organization & Trump will need a lot of help to stop them

America Is Reaching A Boiling Point

The Pandemic Of Fake Psychiatric Diagnoses

This Is How People Actually Use ChatGPT, According To New Research

Texas Man Arrested for Threatening NYC's Mamdani

Man puts down ABC's The View on air

Strong 7.8 quake hits Russia's Kamchatka

My Answer To a Liberal Professor. We both See Collapse But..

Cash Jordan: “Set Them Free”... Mob STORMS ICE HQ, Gets CRUSHED By ‘Deportation Battalion’’

Call The Exterminator: Signs Demanding Violence Against Republicans Posted In DC

Crazy Conspiracy Theorist Asks Questions About Vaccines

New owner of CBS coordinated with former Israeli military chief to counter the country's critics,

BEST VIDEO - Questions Concerning Charlie Kirk,

Douglas Macgregor - IT'S BEGUN - The People Are Rising Up!

Marine Sniper: They're Lying About Charlie Kirk's Death and They Know It!

Mike Johnson Holds 'Private Meeting' With Jewish Leaders, Pledges to Screen Out Anti-Israel GOP Candidates

Jimmy Kimmel’s career over after ‘disgusting’ lies about Charlie Kirk shooter [Plus America's Homosexual-In-Chief checks-In, Clot-Shots, Iryna Zarutska and More!]

1200 Electric School Busses pulled from service due to fires.

Is the Deep State Covering Up Charlie Kirk’s Murder? The FBI’s Bizarre Inconsistencies Exposed

Local Governments Can Be Ignorant Pissers!!

Cash Jordan: Gangs PLUNDER LA Mall... as California’s “NO JAILS” Strategy IMPLODES

Margin Debt Tops Historic $1 Trillion, Your House Will Be Taken Blindly Warns Dohmen

Tucker Carlson LIVE: America After Charlie Kirk

Charlie Kirk allegedly recently refused $150 million from Israel to take more pro Israel stances

"NATO just declared War on Russia!"Co; Douglas Macgregor

If You're Trying To Lose Weight But Gaining Belly Fat, Watch Insulin


Health
See other Health Articles

Title: Model Virus Structure Shows Why There's No Cure for Common Cold
Source: [None]
URL Source: http://www.sciencedaily.com/releases/2013/10/131028162359
Published: Oct 30, 2013
Author: staff
Post Date: 2013-10-30 04:10:27 by Tatarewicz
Keywords: None
Views: 15

ScienceDaily

Oct. 28, 2013 — n a pair of landmark studies that exploit the genetic sequencing of the “missing link” cold virus, rhinovirus C, scientists at the University of Wisconsin-Madison have constructed a three-dimensional model of the pathogen that shows why there is no cure yet for the common cold.

Writing today (Oct. 28, 2013) in the journal Virology, a team led by UW-Madison biochemistry Professor Ann Palmenberg provides a meticulous topographical model of the capsid or protein shell of a cold virus that until 2006 was unknown to science.

Rhinovirus C is believed to be responsible for up to half of all childhood colds, and is a serious complicating factor for respiratory conditions such as asthma. Together with rhinoviruses A and B, the recently discovered virus is responsible for millions of illnesses yearly at an estimated annual cost of more than $40 billion in the United States alone.

The work is important because it sculpts a highly detailed structural model of the virus, showing that the protein shell of the virus is distinct from those of other strains of cold viruses.

“The question we sought to answer was how is it different and what can we do about it? We found it is indeed quite different,” says Palmenberg, noting that the new structure “explains most of the previous failures of drug trials against rhinovirus.”

The A and B families of cold virus, including their three-dimensional structures, have long been known to science as they can easily be grown and studied in the lab. Rhinovirus C, on the other hand, resists culturing and escaped notice entirely until 2006 when “gene chips” and advanced gene sequencing revealed the virus had long been lurking in human cells alongside the more observable A and B virus strains.

The new cold virus model was built “in silico,” drawing on advanced bioinformatics and the genetic sequences of 500 rhinovirus C genomes, which provided the three-dimensional coordinates of the viral capsid.

“It’s a very high-resolution model,” notes Palmenberg, whose group along with a team from the University of Maryland was the first to map the genomes for all known common cold virus strains in 2009. “We can see that it fits the data.”

With a structure in hand, the likelihood that drugs can be designed to effectively thwart colds may be in the offing. Drugs that work well against the A and B strains of cold virus have been developed and advanced to clinical trials. However, their efficacy was blunted because they were built to take advantage of the surface features of the better known strains, whose structures were resolved years ago through X-ray crystallography, a well-established technique for obtaining the structures of critical molecules.

Because all three cold virus strains all contribute to the common cold, drug candidates failed as the surface features that permit rhinovirus C to dock with host cells and evade the immune system were unknown and different from those of rhinovirus A and B.

Based on the new structure, “we predict you’ll have to make a C-specific drug,” explains Holly A. Basta, the lead author of the study and a graduate student working with Palmenberg in the UW-Madison Institute for Molecular Virology. “All the [existing] drugs we tested did not work.”

Antiviral drugs work by attaching to and modifying surface features of the virus. To be effective, a drug, like the right piece of a jigsaw puzzle, must fit and lock into the virus. The lack of a three-dimensional structure for rhinovirus C meant that the pharmaceutical companies designing cold-thwarting drugs were flying blind.

“It has a different receptor and a different receptor-binding platform,” Palmenberg explains. “Because it’s different, we have to go after it in a different way.

Post Comment   Private Reply   Ignore Thread  



[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]